NEWS
Anton Gonak, The Head of Onko & Hospital Unit, “We work for and with our clients”
Anton Gonak started to work for Norameda 14 years ago. According to the young professional, it was a “one-man show” at the time. Today A. Gonak is in charge of the whole division, working in the pharmaceutical market of Oncology, Haematology, and Transplantology....
Norameda Quality Division: reputation worth its weight in gold
"It is our responsibility to ensure that only high quality, safe and effective medicines reach the patients", - says Rasa Kalėdaitė PhD, Qualified Person and Head of the Norameda Quality Division. The Quality Division occupies an essential place in the structure of...
International Day of Rare Diseases – why it is important to talk about it?
Rare diseases affect up to 5 in 10,000 (or 1 in 2,000) people. And though the diseases are rare, rare disease patients are numerous. Currently, there are 5,000 to 8,000 different types of rare diseases known and around 27 to 36 million of the population in the...
The Chiesi Group chooses Norameda
Leber’s Hereditary Optic Neuropathy (LHON) – a devastating diagnosis. It is a heritable genetic disease causing profound vision loss and blindness. Unfortunately, there is no cure. And ways of treatment are limited. The disease presents predominantly in young,...